Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Molecular physiology of nerve terminal bioenergetics

SynaptoEnergy

Synaptic transmission is an extremely energetically-demanding process that consumes 75% of the energy required for brain function. However, it remains poorly understood how synapses guarantee the necessary ATP levels required for neurotransmission. While our understanding of the metabolic pathways for ATP production is vastly detailed, very little...

Funding Programme
Start Date
End Date
Total Funding
€ 1 494 605
European Countries Involved

Molecular Structure and Engineering of Synaptic Organizer Proteins in Health and Disease

SynLink

Synapses are the specialized cellular junctions that form the basic units of communication between neuronal cells. Given the variety of network-dependent functions that synapses need to support, a fundamental question is how their properties are specified at the molecular level. Membrane-anchored and soluble “synaptic organizer proteins” form...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 903
European Countries Involved

Mosaic loss of chromosome Y (LOY) in blood cells - a new biomarker for risk of cancer and Alzheimer’s disease in men

DIALOY

My recent discoveries show that mosaic loss of chromosome Y (LOY) in peripheral blood is associated with increased risks of cancer and Alzheimer’s disease (AD). These conditions are responsible for >50% of morbidity/mortality in aging men. More than 15% of men older than 70 show some degree of LOY and these men survive on average only half as long...

Funding Programme
Start Date
End Date
Total Funding
€ 1 525 000
European Countries Involved

MRI analysis tool for early detection of dementia

MATEDD

Worldwide due to population ageing there will be 75 million patients with Alzheimer's disease by 2030. Alzheimer's is a disease described by accelerated brain ageing which leads to decline in both memory and cognitive skills, thus affecting everyday activities of those suffering. On average over 60% of patients do not receive a diagnosis and...

Funding Programme
Start Date
End Date
Total Funding
€ 75 000
European Countries Involved

MRI based mapping of microscopic brain composition in a mouse model of Alzheimer’s disease

uImaging

This project aims to establish a neuroimaging framework which informs about microscopic brain composition and apply it to study neurodegeneration in a genetic mouse model of Alzheimer’s disease (AD). AD is the most common cause of dementia, characterized by progressive neurodegenerative changes leading to a gradual cognitive loss and memory...

Funding Programme
Start Date
End Date
Total Funding
€ 159 815
European Countries Involved

MRI-based ID of the Vasculature across the Heart-Brain Axis

VascularID

Microvascular impairment is a hallmark of many of todays most burdening diseases, including forms of ischemic heart disease, stroke, and dementia. It is also the most promising candidate to explain the link between cardiovascular and brain disease (so-called heart-brain axis). However, only histology provides comprehensive assessment of the...

Funding Programme
Start Date
End Date
Total Funding
€ 1 852 430
European Countries Involved

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

MIRIADE

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression. With its...

Funding Programme
Start Date
End Date
Total Funding
€ 4 034 565

Multi-Omics-based BIomarker Signatures of dietary Carbohydrates qUalITy and risk of chronic diseaseS.

BISCUITS

The prevalence of type 2 diabetes mellitus (T2D), cardiovascular disease (CVD), and dementia is rapidly increasing worldwide and is therefore a major public health concern. Carbohydrate intake (40-80%) represents the main source of energy in most populations and the quality more than the quantity has a large effect on health. Recently, a...

Funding Programme
Start Date
End Date
Total Funding
€ 222 727
European Countries Involved

Multi-sensory experiences for in-home therapy and entertainment

MOMENTS

Multi-Sensory Environments (MSEs) is a discipline of occupational therapy that helps treat cognitive and sensory deficiencies (in memory, attention, social interaction…) of people with developmental disabilities, physical disabilities, neuro-degenerative diseases and or brain-injuries. These conditions which include autism, dementia, Down syndrome...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Multilevel brain network analyses leading to improved therapeutics for cognitive impairments

COGNITIONNET

Cognitive abilities change with development and age. Cognitive development during childhood and adolescence depends on an intellectually challenging environment, but is robustly affected in various forms of mental retardation. Adult cognitive abilities are strongly correlated with a person’s success in life. Finally, cognitive decline is an...

Funding Programme
Start Date
End Date
Total Funding
€ 3 325 553
European Countries Involved

Multimedia technology for independence and participation for people with dementia

MYLIFE

The objective of Mylife is to support independence for older people with reduced cognitive function by giving them access to simple and intuitive services that are adapted to their individual needs and wishes. The ambition of the Mylife project is to provide network-based access to, and management of, commercially and/or freely available software...

Funding Programme
Start Date
End Date
Total Funding
€ 1 059 973
European Countries Involved

Multimodal Brain Imaging – Gene Relationships in Alzheimer Disease: Risk and Resilience

ADRIAN

The list of genes contributing to increased risk of developing Alzheimers Disease (AD) grows every year. To date, large case-control Genome-Wide Association Studies have found 98 genetic loci associated with late-onset Alzheimer's Disease (LOAD). However, apart from a small number of genes related to familial cases, it remains largely unknown the...

Funding Programme
Start Date
End Date
Total Funding
€ 181 152
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).